BrdU conjugated to KLH
Purified by Protein A.
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.
Store at 4°C for 12 months.
The immunocytochemical detection of bromodeoxyuridine (BrdU) incorporated into DNA is a powerful tool to study the cytokinetics of normal and neoplastic cells. In vitro or in vivo labeling of tumor cells with the thymidine analogue BrdU and the subsequent detection of incorporated BrdU with specific anti-BrdU monoclonal is an accurate and comprehensive method to quantitate the degree of DNA-synthesis.BrdU is incorporated into the newly synthezised DNA of S-phase cells may provide an estimate for the fraction of cells in S-phase. Also dynamic proliferative information such as the S-phase transit rate and the potential doubling time can be obtained, by means of bivariate BrdU/DNA flow cytometric analysis
Predicted Molecular Weight:
Cross Reactive Species:
For research use only. Not intended for diagnostic or therapeutic use.